Company: CERO
Filing Date: 2025-08-22
Form Type: 10-Q
Source: 0001213900-25-079898
Chunk: 196

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-08-22
Form: 10-Q
Item: Item 8
Chunk 196
---
 Series A Preferred Stock, for aggregate cash proceeds of approximately $8.0 million, plus additional
cash proceeds of up to $2.0 million if the Preferred Warrants are exercised.

The
following table summarizes the shares of our Series A Preferred Stock issued to our related parties:

    Purchasers 
    Shares
    of Series A 
    Preferred Stock  
    Total
    Purchase Price 
  
    Daniel Corey(1) 
     150  
    $150,000 
  
    Atwood-Edminster Trust
    dtd 4-2-2000 (2) 
     1,002  
    $1,002,000 
  
    Chris Ehrlich(3) 
     275  
    $275,000 

29

On
February 5, 2025, the Company announced the pricing of a reasonable best efforts public offering (the “Offering”), with participation
from a member of the Company’s board of directors and a single institutional investor, for the purchase and sale of (i) 15,000
shares of common stock, (ii) 112,500 February 2025 Pre-funded Warrants; and (iii) common warrants to purchase up to 127,551 shares of
common stock (the “February 2025 Common Warrants”), at a combined public offering price of $39.20 per share and Warrant (See
Note 8).

The
following table summarizes the pre-funded warrants and February 2025 Common Warrants sold to our related party:

    Purchasers 
    Pre-Funded
    Warrants Purchased  
    Total
    Purchase Price  
    February
    2025 Common Warrants Issued 
  
    Atwood-Edminster
    Trust dtd 4-2-2000 and GVN, LLC (2) 
     25,510  
    $999,992  
     25,510 

  (1) Daniel Corey served as the Chief Technology Officer and a member of the board of directors of the Company from February 2024 to September 2024, and previously served as Chief Executive Officer, Chief Scientific Officer, and a member of the board of directors of Legacy CERo until the closing of the Business Combination in February 2024. 

(2)Brian G. Atwood served as Chairman and Chief Executive Officer of the Company from February 2024 to September 2024, and previously served as